ライブ

Clinical OMICsCancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the Clinic Endpoints NewsHealth groups say HHS is trying to 'rush reinstatement' of ACIP Endpoints NewsB cell therapy maker Be Bio stops hemophilia trial Clinical OMICsFibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLC Endpoints NewsFDA raises no major red flags with Moderna's flu shot FierceBiotechEli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E FierceBiotechAmenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling Thermo FisherThermo Fisher Expands Orbitrap Platform Across Research, Biopharma and Environmental Testing at ASMS 2026 - Lab Manager Clinical OMICsMini Brains Help Identify Treatment for Rare Form Parkinson’s Disease Endpoints NewsFDA greenlights Colorado's drug import proposal CellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM FierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M

Clinical OMICs 2026年6月16日

Fibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLC

The study found that fibroblasts within the tumor microenvironment play a central role in shaping blood vessel formation, oxygen availability, and treatment res...

The study found that fibroblasts within the tumor microenvironment play a central role in shaping blood vessel formation, oxygen availability, and treatment response. The post Fibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLC appeared first on Inside Precision Medicine .